Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone Lymphoma

Clinical trial NCT06712459 · RECRUITING

Trial details

NCT number: NCT06712459
Sponsor: International Extranodal Lymphoma Study Group (IELSG)
Status: RECRUITING
Study type: OBSERVATIONAL

Transformed Splenic Marginal Zone Lymphoma

Start date: 2025-10-13
Primary completion: 2029-03-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.